Indication

Tear film insufficiency

Tear film insufficiency refers to an ocular surface disorder characterized by a quantitative deficiency or qualitative instability in the precorneal tear film, encompassing conditions such as aqueous-deficient dry eye disease and evaporative dry eye states. Read more about Tear film insufficiency

8 drugs 8 manufacturers

Advertisement

Drugs that treat it

Common Tear film insufficiency therapies.

Showing 1–8 of 8 drugs

XIIDRA (lifitegrast)

OPHTHALMIC - ANTI-INFLAMMATORY, IMMUNOMODULATORS·TEAR FILM INSUFFICIENCY
BAUSCH & LOMB P

VEVYE (cyclosporine)

OPHTHALMIC - ANTI-INFLAMMATORY, IMMUNOMODULATORS·TEAR FILM INSUFFICIENCY
HARROW EYE, LLC

XIIDRA (lifitegrast)

OPHTHALMIC - ANTI-INFLAMMATORY, IMMUNOMODULATORS·TEAR FILM INSUFFICIENCY
Novartis Pharmaceuticals
Filter & compare in the drug finder →Opens the drug finder with Tear film insufficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Tear film insufficiency.

Tear film insufficiency refers to an ocular surface disorder characterized by a quantitative deficiency or qualitative instability in the precorneal tear film, encompassing conditions such as aqueous-deficient dry eye disease and evaporative dry eye states.

It affects the ocular system, particularly the cornea and conjunctiva, frequently occurring in older adults, contact lens wearers, and individuals with autoimmune diseases or meibomian gland dysfunction.

Pathophysiologically, lacrimal gland hyposecretion, lipid layer abnormalities, or altered mucin production lead to tear hyperosmolarity, rapid tear film breakup, and ocular surface inflammation.

Patients typically present with ocular discomfort, foreign body sensation, burning, hyperemia, and transient or fluctuating visual disturbances.

Personalize your experience

Follow Tear film insufficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it